Compare Baqsimi or Gvoke With IM Glucagon for Severe Hypoglycemia

November 2019

Baqsimi (bak-SEE-mee) and Gvoke (JEE-vohk) are new glucagon Rxs that will be game changers for treating severe hypoglycemia.

Baqsimi is INTRANASAL glucagon. It's a ready-to-use powder sprayed in one nostril...and is absorbed without inhaling.

Gvoke is a SUBCUTANEOUS injection. It's already mixed and drawn up in a prefilled syringe. An auto-injector will be available next year.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote